Showing 1,261 - 1,280 results of 13,156 for search '(( a ((teer decrease) OR (linear decrease)) ) OR ( a ((latent decrease) OR (largest decrease)) ))', query time: 0.58s Refine Results
  1. 1261
  2. 1262
  3. 1263
  4. 1264
  5. 1265
  6. 1266
  7. 1267

    Table_1_Positive Affect Over Time and Emotion Regulation Strategies: Exploring Trajectories With Latent Growth Mixture Model Analysis.docx by Margherita Brondino (9145631)

    Published 2020
    “…We identified three trajectories of PA over time: a constantly high PA profile, an increasing PA profile, and a decreasing PA profile. …”
  8. 1268

    Data_Sheet_1_Prevalence of respiratory disease in Irish preweaned dairy calves using hierarchical Bayesian latent class analysis.docx by John D. Donlon (15215203)

    Published 2023
    “…Introduction<p>Bovine respiratory disease (BRD) has a significant impact on the health and welfare of dairy calves. …”
  9. 1269
  10. 1270

    Data_Sheet_1_Latent Profiles and Influencing Factors of Posttraumatic Stress Symptoms Among Adults During the COVID-19 Pandemic.pdf by Wenjie Duan (733294)

    Published 2021
    “…<p>The COVID-19 pandemic severely affected public health and the prevalence of posttraumatic stress symptoms among adults in Hubei Province, China. In this study, a total of 2,930 (662 males and 2,268 females) adults answered a questionnaire obtaining information on their demographics, posttraumatic stress symptoms (i.e., intrusion and avoidance), social media exposure, social media involvement, and self-efficacy. …”
  11. 1271

    Table_1_B21 DNA vaccine expressing ag85b, rv2029c, and rv1738 confers a robust therapeutic effect against latent Mycobacterium tuberculosis infection.docx by Shufeng Weng (14229689)

    Published 2022
    “…Mycobacterium tuberculosis (M. tb) expression profiles differ at different growth periods, and vaccines protective and therapeutic effects may increase when they include antigenic compositions from different periods. To develop a post-exposure vaccine that targets LTBI, we constructed four therapeutic DNA vaccines (A39, B37, B31, and B21) using different combinations of antigens from the proliferation phase (Ag85A, Ag85B), PE/PPE family (Rv3425), and latent phase (Rv2029c, Rv1813c, Rv1738). …”
  12. 1272

    Presentation_1_B21 DNA vaccine expressing ag85b, rv2029c, and rv1738 confers a robust therapeutic effect against latent Mycobacterium tuberculosis infection.pptx by Shufeng Weng (14229689)

    Published 2022
    “…Mycobacterium tuberculosis (M. tb) expression profiles differ at different growth periods, and vaccines protective and therapeutic effects may increase when they include antigenic compositions from different periods. To develop a post-exposure vaccine that targets LTBI, we constructed four therapeutic DNA vaccines (A39, B37, B31, and B21) using different combinations of antigens from the proliferation phase (Ag85A, Ag85B), PE/PPE family (Rv3425), and latent phase (Rv2029c, Rv1813c, Rv1738). …”
  13. 1273
  14. 1274
  15. 1275
  16. 1276
  17. 1277

    Proteinuria increases in proportion to podocyte number per glomerular tuft and podocyte density decrease. by Larysa Wickman (3169548)

    Published 2016
    “…<p><b>Panel A:</b> Urine PCR shown on a linear scale in relation to podocyte density demonstrating that as podocyte density decreases below approximately 100 per 10<sup>6</sup> um<sup>3</sup> the level of proteinuria exponentially increases. …”
  18. 1278

    Pain intensity amplification with either increases or decreases are independent of temperature but are correlated with each other. by Benedict J. Alter (9745466)

    Published 2020
    “…No correlation exists between stimulus intensity (heat pain threshold (A or C) or T1 stimulus temperature used (B or D)) and pain intensity modulation during the t3 period by either preceding noxious temperature decreases (OS Min-T1) or increases (Inv Max-T2). …”
  19. 1279
  20. 1280